1) lung fiberalition type
肺纤维化型
1.
Methods: 60 patients with COPD were rFEV1andomly divided into 2 groups,30 patients in A group were indicated gas swelling type in chest x-ray,30 patients in B group were indicated lung fiberalition type.
方法:将选取的60例稳定期的COPD的患者分为两组,A组30例,胸片提示为肺气肿型,B组30例,胸片提示为肺纤维化型,两组均给予噻托溴胺粉雾剂吸入治疗。
2) Pulmonary fibrosis
肺纤维化
1.
Effect of Matrine and IFN-γ on Bleomycin-induced pulmonary fibrosis;
苦参碱、γ干扰素对大鼠肺纤维化干预作用
2.
The mechanisms of low molecular heparin in relieving pulmonary fibrosis in rats;
低分子肝素减轻大鼠肺纤维化机制探讨
3.
Origin and role of myofibroblast in pulmonary fibrosis;
肌成纤维细胞在肺纤维化中的来源和作用
3) lung fibrosis
肺纤维化
1.
Influence of qi-replenishing and blood-activating therapy on levels of IFN-γ and IL-4 in mice with lung fibrosis induced by bleomycin;
益气活血法对博莱霉素致肺纤维化小鼠IFN-γ、IL-4的影响
2.
An analysis of sleep respiratory in inpatients with lung fibrosis;
肺纤维化住院患者睡眠呼吸分析
3.
Influence of different dosages of dexamethasone on bleomycin-induced lung fibrosis in rats
不同剂量地塞米松对博莱霉素致大鼠肺纤维化的影响
4) the Pulmonary fibrosis model of rat
大鼠肺纤维化模型
1.
Methods: Establishing the Pulmonary fibrosis model of rat in accordance with method of Snidert to perfus stomach with tetrandrine(30mg.
方法：依照Snider法建立大鼠肺纤维化模型。
5) silicosis fibrosis
矽肺纤维化
1.
The article is written to investigate the storage model of silicosis fibrosis bioactive medium, via give a research in NXD theory, and via analyze the main NXD.
本文旨在通过对NXD理论的研究,和对主流NXD的分析,来探讨矽肺纤维化生物活性介质数据的存储模型。
2.
OBJECTIVE The aim of this study was to investigate the effect and mechanism of curcumin in the pathogenesis of silicosis fibrosis in mice METHODS 1.
目的 建立小鼠矽肺纤维化动物模型,经灌胃给予不同剂量姜黄素,旨在研究 1。
6) Human Pulmonary Fibrosis
人肺纤维化
1.
The Expression of Urotensin Ⅱ and Its Role in Human Pulmonary Fibrosis;
尾加压素Ⅱ在人肺纤维化组织中的表达及意义
补充资料：肺纤维化
肺纤维化
由于炎症、遗传因素和免疫功能异常等原因，致使肺实质和间质纤维组织增生、肺泡壁显著增厚、肺毛细血管床减少、细支气管狭窄和闭塞等病理改变的总称。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条